Clostridium difficile has emerged as a pathogen or commensal in food animals. There is overlap between isolates from animals, retail meats and humans, suggesting that animals may be a C. difficile reservoir. For direct detection of variant C. difficile strains in faecal samples of symptomatic and asymptomatic animals, we developed and validated a new TaqMan real-time PCR (TMrtPCR) assay targeting the tcdA, tcdB and cdtB genes. We compared it with the enrichment culture method and with two real-time PCR (rtPCR) assays, BrtPCR and PCRFast, targeting tcdB and tcdA/tcdB, respectively. All ten tested C. difficile toxinotypes, except one (XIa) with PCRFast and two (X, XIa) with BrtPCR, were detected with the test assays. A total of 340 (100 %) samples were cultured and amplified with TMrtPCR. Results correlated in 75.3 % samples. Forty (11.8 %) samples were culture positive/TMrtPCR negative, possibly because of the low numbers of bacteria in the samples or because of DNA extraction failure. Forty (11.8 %) samples were TMrtPCR positive/culture negative. Among 79 samples included in the rtPCR assays/culture comparison, 50.6 % were in complete concordance. The results showed that TMrtPCR performed better than BrtPCR and PCRFast, and 67 % of the culture-positive samples were TMrtPCR positive in comparison to 40 % of the samples positive in BrtPCR and 7 % of the samples positive in PCRFast, respectively. Another advantage of TMrtPCR over BrtPCR and PCRFast is its ability to detect a binary toxin gene. Therefore, the TMrtPCR results can provide the first information about the toxin type present in the sample. According to the results of our study, TMrtPCR could be a preferred screening method for the rapid detection of C. difficile in animal faecal samples, although an enrichment culture has to be performed for the specimens with negative or inconclusive rtPCR results.
INTRODUCTION
Clostridium difficile-associated disease (CDAD) or asymptomatic carriage of toxigenic C. difficile has been described for numerous animals, including piglets, calves and broiler chickens (Rodriguez-Palacios et al., 2006; Songer & Anderson, 2006; Hammitt et al., 2008; Pirs et al., 2008; Simango & Mwakurudza, 2008; Zidaric et al., 2008; Alvarez-Perez et al., 2009 ). Variant C. difficile strains with binary toxin CDT are often isolated from animals and these strains seem to be associated with community-acquired C. difficile infections (CA-CDIs) in humans (Rupnik, 2007; Jhung et al., 2008; Limbago et al., 2009) . The increased frequency and severity of CA-CDIs has resulted in an increasing interest in understanding the relationship between animal and human strains of C. difficile, and consequently in diagnostic methods (Barbut et al., 2005; Pituch, 2009 ).
C. difficile or its toxins, are usually diagnosed by a combination of cell cytotoxicity assay, specific culture followed by in vitro toxin detection of the isolated strains (toxigenic culture) and enzyme immunoassays (Crobach et al., 2009) . These methods are either labour intensive and time-consuming or lacking in sensitivity and specificity. In contrast to the situation in humans, the results of commercial toxin tests in animal faecal samples often correlate poorly with culture results (Rodriguez-Palacios et al., 2006; Pirs et al., 2008) . Rapid real-time PCR (rtPCR) methods have been described for the detection of C. difficile directly from human faeces. These rtPCR protocols target either 16S rRNA (Rinttilä et al., 2004; Penders et al., 2005; Tonooka et al., 2005) or only one gene (tcdB, tcdC) (Van den Berg et al., 2006; Peterson et al., 2007; Sloan et al., 2008; Larson et al., 2010) . SYBR Green is also commonly used, even though it has its drawbacks in terms of specificity (Rinttilä et al., 2004; Tonooka et al., 2005; Peterson et al., 2007) . Wroblewski et al. (2009) developed a TaqMan-based multiplex rtPCR targeting the genes encoding toxins A and B, and binary toxin, but the method has been validated only for human samples. Three commercially available rtPCR assays have been recently approved by the US Food and Drug Administration -BD GeneOhm Cdiff (BD Diagnostics) (Stamper et al., 2009) ; ProGastro Cd (Prodesse) (Doing et al., 2010) ; and Cepheid Xpert C. difficile (Cepheid) (Huang et al., 2009) . These systems require special instruments and kits, which represent additional costs for diagnostic laboratories. Furthermore, all commercial tests (enzyme immunoassays and rtPCR) have been validated only for humans with CDAD. A rapid, simple and sensitive method, capable of detecting variant strains, is required for laboratory detection of C. difficile in symptomatic and asymptomatic animals. To the best of our knowledge, only one study dealing with the comparison of a rtPCR with the culture method for the detection of C. difficile in animal samples has so far been published (Houser et al., 2010) .
The objectives of this study were (i) to develop and validate a new TaqMan real-time PCR (TMrtPCR) targeting genes for toxins A and B, and binary toxin, for direct detection of C. difficile in animal faecal samples; (ii) to compare it with a commercial PCRFast Clostridium difficile A/B test (PCRFast) (ifp Institut für Produktqualitet) and with rtPCR targeting tcdB (BrtPCR), using published primers and probe (Van den Berg et al., 2006); and (iii) to compare rtPCR assays with the culture method.
METHODS
Bacterial strains. The bacterial strains used in this study are listed in Table 1 . The specificity of the TMrtPCR was demonstrated by testing 28 non-C. difficile strains, among them 18 Clostridium sp. strains (Table 1) .
Animals and sampling. A total of 340 samples from different farm animals were collected. From piglets (,10 days old) 285 rectal swabs in duplicate (one for cultivation and one for DNA extraction) were obtained. The samples were taken from five piglets per litter on four different large farms (total animal number .1000) and four different small farms (total animal number ,500). Of the 52 litters sampled, 53.8 % were with at least one diarrhoeic animal, while 46.2 % litters were with animals without diarrhoea. Faecal samples from 51 diarrhoeic calves (,10 days old) from two different farms and four samples from diarrhoeic foals (up to 1 month of age) were also investigated.
Bacteriological cultivation and identification. Samples were inoculated into a 9 ml cycloserine cefoxitin fructose enrichment broth (Oxoid) supplemented with 0.1 % sodium taurocholate (Sigma-Aldrich). After 7 days of incubation at 37 uC in anaerobic jars, 1 ml was transferred into a sterile test tube and mixed with an equal amount of absolute ethanol and left at room temperature for 30 min. Samples were centrifuged and the pellet was plated onto a standard selective medium with cycloserine and cefoxitin (C. difficile agar base and C. difficile selective supplement; Oxoid). The inoculated plates were incubated anaerobically at 37 uC for 2 days (Arroyo et al., 2005) . The isolates were identified on the basis of morphological criteria, typical odour, and confirmed with multiplex PCR targeting tpi, tcdA and tcdB (Lemee et al., 2004) .
DNA extraction. Rectal swabs were washed in 700 ml sterile distilled water and 200 ml of the suspension obtained was used for DNA extraction. DNA from rectal swabs and faecal samples was extracted using the QIAamp DNA stool mini kit (Qiagen).
DNA from bacterial isolates was purified from colonies grown on blood agar (BBL Columbia agar base supplemented with 5 % ovine blood; Becton Dickinson) by heating the bacterial suspensions at 95 uC for 15 min and then centrifuging for 2 min at 14 000 g. Supernatants were used as a source of DNA for rtPCR.
TMrtPCR
Primers and probes. The tcdA, tcdB and cdtB C. difficile toxin gene sequences available from public databases and sequences kindly provided by Maja Rupnik (Institute for Public Health, Maribor, Slovenia) were analysed. Sequence alignments revealed conserved and specific regions for all genes. Using sequences within these regions, primers and probes were designed and synthesized by Applied Biosystems. The sequences of the amplification primers and probes are listed in Table 2 .
PCR conditions. For the detection of tcdA, tcdB and cdtB genes, three reactions were prepared in a total volume of 10 ml, containing 16TaqMan universal PCR master mix (Applied Biosystems), 16assay mix [mix of 900 nM both PCR primers and 200 nM TaqMan MGB (minor groove binder) probe -FAM (6-carboxyfluorescein) dye-labelled], and 1 ml DNA template. PCR amplification (2 min at 50 uC, 10 min at 95 uC, followed by 45 cycles of 15 s at 95 uC and 1 min at 60 uC) and detection were carried out with an ABI Prism 7000 sequence detection system (Applied Biosystems).
Internal inhibition control. The TaqMan exogenous internal positive control reagents (Applied Biosystems) were used for the detection of DNA polymerase inhibitors, possibly present in DNA preparations from faecal samples. The kit provides an internal positive control DNA template (Exo IPC DNA) and a mix of primers and VIC dyelabelled probes for amplification and specific detection of internal positive control DNA (Exo IPC mix). To analyse the presence of potential PCR inhibitors in each of the faecal samples tested, an amplification control reaction was carried out. Each 25 ml reaction mixture comprised 12.5 ml TaqMan universal PCR master mix (Applied Biosystems), 1.5 ml assay mix for the detection of tcdA, tcdB or cdtB genes, 2.5 ml Exo IPC mix, 5.5 ml sterile water, 0.5 ml Exo IPC DNA (diluted 1 : 500) and 2.5 ml DNA template. PCR amplification and detection conditions were the same as described above.
Specificity and analytical sensitivity. The specificity of the assay was determined by testing the DNA from 39 bacterial strains, as shown in Table 1 . The limit of detection (LOD) of the TMrtPCR for each target gene, with and without internal control, was determined by spiking C. difficile-negative faecal specimens with 10-fold serial dilutions (10 21 to 10 26 ) of C. difficile cells (strain 51377, A
, grown in a brain heart infusion broth (Oxoid). Each C. difficile dilution was spiked in triplicate. The number of C. difficile cells in the broth was counted with a microscope. DNA extraction and amplification were performed as described above. Each DNA extract was tested three times with TMrtPCR.
PCRFast Clostridium difficile A/B test. A total of 79 samples (42 culture positive and 37 culture negative) were subjected to PCRFast, performed according to the manufacturer's instructions on an ABI Prism 7000 sequence detection system with the TaqMan universal PCR master mix (Applied Biosystems). An initial step (2 min at 50 uC) for AmpErase UNG (uracil N-glycosylase) activity of the master mix was added to the amplification programme according to the manufacturer's instructions.
rtPCR targeting tcdB. The same 79 samples that were used for PCRFast were also amplified with BrtPCR. Primers 398CLDs/ 399CLDas and probe 551CLD-tq-FAM were used (Van den Berg et al., 2006) . The reaction mixture and cycling conditions were the same as for TMrtPCR (described above).
RESULTS

Specificity and analytical sensitivity of TMrtPCR
The specificity of the primers and probes used for TMrtPCR was determined to be 100 %, as all non-C. difficile bacterial strains were negative for all three genes and all C. difficile strains were positive for the respective genes (Table 3 ). In case of toxinotypes VIII (A 2 B + CDT 2 ) and XIa (A 2 B 2 CDT + ), the assay targeting tcdA was positive, since the gene for toxin A is present but not expressed in these toxinotypes.
The LOD of the TMrtPCR for tcdB and cdtB genes was found to be 440 copies C. difficile DNA (g faeces) 21 (100 % probability of detection). The LOD for tcdA gene was below 440 copies DNA (g faeces)
21
, while two triplicates with 44 copies DNA (g faeces)
, were positive in TMrtPCR. When using the internal control in a duplex assay with rtPCR for tcdA or tcdB gene, the LOD was the same as for rtPCR without the internal control. However, in the case of cdtB gene detection, not only was the LOD higher [at least 4400 copies DNA (g faeces 21 )], but also two triplicates with 440 copies DNA (g faeces) 21 were positive in TMrtPCR. 
NFQ, Nonfluorescent quencher.
Clostridium difficile real-time PCR
Detection of variant C. difficile toxinotypes with rtPCR assays
Eight tested toxinotypes (0, I, IIIb, IV, V, VI, VIII, XII) of C. difficile were detected with all three rtPCR assays (Table  3) . Toxinotype XIa (A 2 B 2 CDT + ) was negative in PCRFast and BrtPCR, while toxinotype X (A 2 B + CDT + ) was negative in BrtPCR (Table 3) Table 4 .
The correlation of TMrtPCR with the cultivation results is shown in Table 5 . Results of TMrtPCR for four culturepositive samples were not in complete concordance with the A + B + CDT + type defined for C. difficile isolates, while TMrtPCR for tcdA or cdtB was negative.
Comparison of all three rtPCR assays and the culture method
The highest number of culture-positive samples gave positive results also in TMrtPCR (57 %), while only 40 and 7 % of the samples were positive in BrtPCR and PCRFast, respectively (Table 6 ). Four culture-positive samples (10 %) that were unresolved by TMrtPCR, as described above, were negative in both BrtPCR and PCRFast assays.
Inhibitors were not detected for TMrtPCR, while inhibition was observed in four samples for PCRFast. One inhibited sample was culture/TMrtPCR/BrtPCR positive, two were culture positive/rtPCR negative and one was culture/rtPCR negative.
Among 79 samples, 40 (50.6 %) were in complete concordance (all three rtPCR assays showed the same result) -19 were culture negative/rtPCR negative, 4 were culture negative/rtPCR positive, 14 were culture positive/ rtPCR negative and 3 were culture positive/rtPCR positive. However, two culture-positive samples (toxinotype XIa; data not shown) yielded an A + B 2 CDT + result with TMrtPCR, while BrtPCR and PCRFast, targeting only tcdA and/or tcdB, were negative. These two samples were designated rtPCR positive, as the negative result with BrtPCR and PCRFast was correct. Additionally, among the 39 (49.4 %) samples that were not in complete concordance, BrtPCR results of 23 (59.0 %) samples were in accordance with TMrtPCR results, but not with PCRFast results. However, five culture-negative samples (12.8 %) were positive in TMrtPCR and three of them were also positive in PCRFast, while all five samples were negative in BrtPCR. Of the 39 samples, only these 3 (7.7 %) gave the same result in PCRFast and TMrtPCR.
DISCUSSION
Low carriage rates of toxigenic C. difficile strains with no detectable level of toxin might indicate carriage rather than an infection of the animal. These animals could serve as reservoirs for other animals (e.g. during hospitalization) and also for humans (Indra et al., 2009; Gould & Limbago, 2010) . Detection of C. difficile in asymptomatic animals with potentially severe strains is therefore very important. In such cases enrichment culture is necessary but it is timeconsuming and not specific for identification of toxigenic strains (Båverud, 2002; Arroyo et al., 2005) . Therefore, we developed and validated a new TMrtPCR for faster detection of toxigenic strains directly in the faeces of symptomatic and asymptomatic animals, and performed a comparison with the enrichment culture method and with two existing rtPCR assays.
The results obtained with TMrtPCR correlate with culture in 75.3 % samples. Forty (11.8 %) culture-positive samples were TMrtPCR negative. This could be connected with the number of C. difficile cells contained in the faecal sample. As the latter is never a homogeneous medium, the concentration of bacteria may vary. Rectal swabs used for sampling young animals contain a smaller amount of faeces, the swab washing prior to the DNA extraction employed in our study may have reduced the concentration of bacteria. It could also be a DNA extraction failure, since in case of samples from asymptomatic animals, a small amount of bacteria, especially clostridial spores, is expected. Forty samples (11.8 %) were TMrtPCR positive but were not detected by the enrichment culture. TMrtPCR results were not regarded as false positive as every sample was tested three times (detection of three toxin genes) and as the toxin type results correlated with the type presented on the sampled farm (Avbersek et al., 2009) . However, 18/ 40 culture-negative/TMrtPCR-positive samples were also tested with BrtPCR and PCRFast -16 samples were also positive with BrtPCR and/or PCRFast. Only two samples were negative with BrtPCR and PCRFast. Due to its high sensitivity, the TMrtPCR assay was able to detect low concentrations of target DNA in samples in which the amount of C. difficile was insufficient to grow in enrichment media or in which the DNA was extracted from bacteria that did not survive in the sample before cultivation. It should be noted that the culture method is not designated a 'gold standard' and it is not a standardized procedure. In spite of alcohol shock after enrichment, other anaerobic sporogenic bacterial flora could be present, which could overgrow C. difficile colonies. The results of our study agree with the findings published by Houser et al. (2010) . This study reported 7.0 % culture-positive/rtPCRnegative and 11.3 % culture-negative/rtPCR-positive faecal samples from calves. The sensitivity of the rtPCR assay was increased if faecal samples were enriched before DNA extraction (Houser et al., 2010) .
As variant toxinotypes have emerged in humans and animals, it is important for diagnostic methods to detect as many different toxinotypes as possible (Rupnik, 2007) . In this study, ten toxinotypes were tested in all three rtPCR assays. With the exception of one (XIa) in PCRFast and two (X, XIa) in BrtPCR, all toxinotypes were detected with the test assays. Toxinotype XIa (only binary toxin positive) was negative, because PCRFast and BrtPCR do not detect the (McEllistrem et al., 2005) , although the detection of three genes raises the price of the assay. Results for the samples that were not in complete concordance (49.4 %) show that BrtPCR performed better than PCRFast, as the results correlated better with the culture and TMrtPCR results. However, BrtPCR was not able to detect toxinotype X, which could lead to a false-negative rtPCR result. The manufacturer's instructions for PCRFast, however, do not specify whether the kit has been validated on animal samples and, to the best of our knowledge, BrtPCR was used here on animal samples for the first time.
It should be noted that a different master mix than the one suggested in the manufacturer's instructions was used for PCRFast, as the results obtained by using the AmpliTaq Gold PCR master mix (Applied Biosystems) were invalid. Therefore, further testing of PCRFast with other PCR reagents is required.
In conclusion, this study describes a novel TMrtPCR for the direct detection of C. difficile in animal faecal samples.
TMrtPCR targets the genes for toxins A and B, and binary toxin; detection of the latter is becoming more important due to its potential clinical significance and association with CA-CDI. TMrtPCR could be the preferred screening method, because of its advantages: it is faster and it provides the first information about the toxin type. Because of possible false negative TMrtPCR results, enrichment culture should be performed for the specimens with negative or inconclusive rtPCR results as a second step for C. difficile detection in animal samples. However, as the isolate is often necessary for genotyping studies, the importance of the culture should not be underestimated. This study also demonstrated that the validation of rtPCR with animal samples should be carried out, as rtPCR assays designed for CDAD diagnosis in humans may be inadequate. The new TMrtPCR could also be used for the detection of C. difficile in environmental samples (e.g. water, soil, surface swabs taken in hospitals) or in food samples, in which low numbers of C. difficile are expected. To prevent false-negative rtPCR results DNA extraction from enriched samples should be performed. Further studies should also evaluate different DNA extraction methods from spores, which could result in more rtPCRpositive samples. 
